Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

25 Mar 2022 · Michael Lovesey
Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
Join our investor conference on 31 March – Technology focused virtual event!
Read article
24 Mar 2022 · Jane Lowe
UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)
UniSuper is making its first major foray into venture capital investing, tipping $75 million into the shared investment arm of the nation’s research agency, CSIRO, and four major Australian universi...
Read article
24 Mar 2022 · Michael Lovesey
Servatus launches new trial into the effects of live biotherapeutics on insomnia
Servatus CEO Dr Wayne Finlayson discusses the company’s new human clinical trial into the link between the gut microbiome and sleep by treating patients who suffer from insomnia with live…
Read article
24 Mar 2022 · Paul Langley
CEO in focus - Pureprofile's Martin Filz
We speak with Pureprofile's (ASX:PPL) inspirational leader, Martin Filz, about what makes him tick.
Read article
23 Mar 2022 · Paul Langley
Recent client coverage highlights
John Kelly spoke with Jack Crnjanin on Joy 94.9 Radio’s Well Well Well podcast about the Atomo HIV self-test and the health and awareness benefits to come from the TGA’s recent amendments to rules.
Read article
23 Mar 2022 · Cherie Hartley
Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer
Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)
Read article
21 Mar 2022 · Admin
Project: 2025
We are delighted to showcase a select number of emerging ASX listed tech companies on 31 March. The free virtual event will focus on companies that are paving the way forward with major advances in te...
Read article
17 Mar 2022 · Jane Lowe
XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference
XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference
Read article
16 Mar 2022 · Cherie Hartley
Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference
Race Oncology (ASX:RAC) CEO Phil Lynch provides an update on the Company’s activities and new strategy as part of their participation in the ASX Small and Mid-Cap Conference 2022.
Read article
11 Mar 2022 · Jane Lowe
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
"The smart money in medicine: combatting fibrosis"
Read article